Michelle Lupton

Has grant

Team Head

QIMR Berghofer Medical Research Institute
Country flagAustralia

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Recent Grants

Grant: Close

Advancing drug repositioning and development for Alzheimer's Disease using functional genomics and computational phenomics

Open Date: 2021-09-05

Close Date: 2023-08-31

Grant: Close

Blood testing to predict and discriminate dementias

Open Date: 2021-06-11

Close Date: 2026-05-31

Grant: Close

Methylation-based biomarkers for prodromal Alzheimer’s disease

Open Date: 2021-01-01

Close Date: 2022-01-01

Grant: Close

Genetic Investigations for Prodromal Alzheimerâ s disease

Open Date: 2018-01-01

Close Date: 2021-12-31

Grant: Close

Women’s Academic Fund. Carer Funding

Open Date: 2017-01-01

Close Date: 2017-01-01

Articles (7)

Year:

2026

Year:

2026

Year:

2026

Biomarkers from diverse methodological domains are increasingly important in the detection, diagnosis and tracking of neurological diseases and brain health, yet they are often evaluated in isolation. Statistical integration approaches, such as factor analysis, provide a means to combine complementary biomarkers and capture higher-order domains of brain health. Exploratory factor analysis has previously been employed to identify latent brain health constructs using multimodal MRI, fluid biomarkers and cardiovascular risk factors in a non-clinical older population. The current study aimed to validate this integrative framework using confirmatory factor analysis in an independent cohort and test construct associations with cognition and diagnosis of mild cognitive impairment (MCI) or Alzheimer’s disease (AD) dementia. Data were analysed from 197 participants in the Prospective Imaging Study of Ageing, including 157 cognitively normal controls (CN), 18 participants with MCI and 22 participants with early AD dementia. MRI, cardiovascular, and plasma biomarker processing closely replicated previous methods. Confirmatory factor analysis was conducted in CNs to validate the previously reported latent constructs. Weighted factor composites were then compared between each diagnostic group and tested for associations with cognitive performance (verbal reasoning, verbal memory, visual memory and language) and sensitivity to MCI and AD diagnosis. Three factors were reproducible across cohorts: 1) Brain & Vascular Health (hippocampal and ventricular volumes, cerebral blood flow); 2) White Matter (WM) Fluid Dysregulation (Free Water, WM enlarged perivascular spaces); and 3) Blood Biomarkers (GFAP, NfL, pTau181). Compared to the CN group, both MCI (β=−1.25, SE=0.19, p <.001) and AD dementia (β=−1.52, SE=0.16, p <.001) participants had lower Brain & Vascular Health composite scores. MCI (β=0.80, SE=0.20, p <.001) and AD dementia (β=1.85, SE=0.17, p <.001) participants also had higher Blood Biomarkers composite scores than CNs, but there was no difference in WM Fluid Dysregulation scores across groups (F (2,192) = 0.89, p =.411). The Brain & Vascular Health composite had the strongest association with MCI/AD dementia among all individual measures and composites. Across all participants, Brain & Vascular Health and Blood Biomarkers composite scores were associated with tests of cognition ( p <.0125), while WM Fluid Dysregulation did not show any significant associations. These findings demonstrate that reproducible, multimodal composites can index distinct yet complementary dimensions of brain health relevant to cognition and AD dementia. Importantly, this work highlights the value of an adaptable, integrative framework for combining imaging and plasma biomarkers to characterise system-level brain health and support early detection and mechanistic investigation of cognitive decline and neurodegenerative disease.

Year:

2026

Year:

2025

Background Alzheimer’s dementia (AD) is a leading cause of disability and dependency in older adults. Frailty is a phenotypic risk factor for AD, but its causal role remains unclear - partly due to reliance on composite scores that may obscure distinct mechanisms. Methods We applied a Mendelian randomisation (MR) framework using two large GWAS of clinically diagnosed AD. Frailty exposures were derived from a multivariate genomic SEM model comprising one general factor and six domain-specific domains. Bidirectional univariable MR (UVMR) estimated total effects on AD, while multivariable MR (MVMR) adjusted for educational attainment, household income, and longevity. Results The general frailty factor showed no evidence of a causal effect on AD. The unhealthy lifestyle frailty domain increased AD risk in UVMR (OR = 6.60, 95% CI: 2.36-18.50, q = 0.021 and OR = 3.12, 95% CI: 1.57-6.19, q = 0.001), but these effects attenuated substantially in MVMR, with betas reduced by ∼66-94% and ORs falling to ∼1.1-1.5 (non-significant), consistent with overlap with socioeconomic pathways. The disability frailty domain was nominally protective in UVMR, but positively associated with AD in MVMR (OR = 1.69, 95% CI: 1.21-2.36, q = 0.007). The poorer cognition frailty domain increased AD risk in MVMR when adjusted for education and income (OR = 1.55, 95% CI: 1.12-2.15, q = 0.025), though this effect attenuated by ∼37% with further adjustment for longevity. Sensitivity analyses indicated that this cognition-AD signal was partly driven by SNPs in SPI1, a well-established AD risk locus, consistent with pleiotropic overlap rather than an independent domain. No reverse effects were observed. Conclusions Frailty comprises genetically distinct domains with differential causal relevance for AD. These findings highlight disability-related frailty as a potential causal contributor to AD, whereas cognitive frailty is likely predominantly driven by shared aetiology, -underscoring the need to move beyond composite frailty indices when evaluating dementia risk.

Year:

2025

Frailty is a multifaceted clinical state associated with accelerated aging and adverse health outcomes. Informed etiological models of frailty hold promise for producing widespread health improvements across the aging population. Frailty is currently measured using aggregate scores, which obscure etiological pathways that are only relevant to subcomponents of frailty. Therefore, we performed the first multivariate genome-wide association study of the latent genetic architecture between 30 frailty deficits, which identified 408 genomic risk loci. Our model included a general factor of genetic overlap across all deficits, plus six novel factors indexing shared genetic signal across specific groups of deficits. Follow-up analyses demonstrated the added clinical and etiological value of the six factors, including predicting frailty in external datasets, divergent genetic correlations with clinically relevant outcomes, and unique underlying biology linked to aging. This suggests nuanced models of frailty are key to understanding its causes and how it relates to worse health.

Year:

2024

Collaborators (27)

Jurgen Fripp

Biomedical Informatics Group Leader

CSIRO

AUSTRALIA
View details

Nicholas Ashton

Assistant Professor

Banner Alzheimer’s Institute

UNITED STATES
View details

Henrik Zetterberg

Professor

University of Gothenburg

SWEDEN
View details

Ian H. Harding

Group Leader

QIMR Berghofer Medical Research Institute

AUSTRALIA
View details

Tom C. Russ

Reader in Old Age Psychiatry

University of Edinburgh

UNITED KINGDOM
View details

Isabelle Francesca Foote

Lecturer in Genomics and Ageing

Queen Mary University of London

UNITED KINGDOM
View details

Tobias Karakach

Assistant Professor

Dalhousie University

CANADA
View details

Alan Marshall

Senior Lecturer in Quantitative Methods

University of Edinburgh

UNITED KINGDOM
View details

Donncha Mullin

Honorary Clinical Lecturer

University of Edinburgh

UNITED KINGDOM
View details

Simon R. Cox

Personal Chair of Brain and Cognitive Ageing

University of Edinburgh

UNITED KINGDOM
View details

Matthew Pase

Associate Professor

MONASH UNIVERSITY

AUSTRALIA
View details

Andrew Grotzinger

Associate Professor

Memorial University of Newfoundland

CANADA
View details

Brittany Mitchell

Senior Research Fellow

QIMR Berghofer Medical Research Institute

AUSTRALIA
View details

David D. Ward

University of Queensland

AUSTRALIA
View details

Kenneth Rockwood

Professor

Nova Scotia Health Authority

CANADA
View details

Janice Ranson

Senior Research Fellow

University of Exeter

UNITED KINGDOM
View details

Anna Elisabeth Fürtjes

Research Associate in Statistical Genetics

University of Edinburgh

UNITED KINGDOM
View details

David Whiteman

Deputy Director

QIMR Berghofer Medical Research Institute

AUSTRALIA
View details

Meng Law

Professor and Director of Radiology

MONASH UNIVERSITY

AUSTRALIA
View details

Andrew D. Rutenberg

Dalhousie University

CANADA
View details

Enda Byrne

Senior Research Fellow

University of Queensland

AUSTRALIA
View details

Nicholas Martin

Senior Scientist and Senior Principal Research Fellow

QIMR Berghofer Medical Research Institute

AUSTRALIA
View details

Anna Behler

Newcastle University

AUSTRALIA
View details

Catherine Olsen

QIMR Berghofer Medical Research Institute

AUSTRALIA
View details

Michael Breakspear

Professor

Newcastle University

AUSTRALIA
View details

Gail A. Robinson

University of Queensland

AUSTRALIA
View details

Michelle Luciano

University of Edinburgh

UNITED KINGDOM
View details